SCHEMBL12856496

SCHEMBL12856496

Cc1cc(C)cc(N(c2ccc3ccccc3c2)c2ccc3ccc4c(N(c5cc(C)cc(C)c5)c5ccc6ccccc6c5)ccc5ccc2c3c54)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.38
CYP2A6 P11509 2/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP3A4 P08684 4/20 0.35
HSD17B10 Q99714 4/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 2/20 0.35
CYP1A2 P05177 4/20 0.33
ERBB2 P04626 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
MAPK1 P28482 2/20 0.32
NR1I2 O75469 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13333766 0.90 CYP1A2 (0.42) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL12856443 0.90 L3MBTL1 (0.44) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL12856520 0.89 CYP1A2 (0.40) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL15137921 0.88 ALDH1A1 (0.47) TDP1CYP2A6L3MBTL1CYP3A4HSD17B10
SCHEMBL10354363 0.87 ALDH1A1 (0.35) TDP1CYP2A6L3MBTL1CYP3A4HSD17B10
SCHEMBL10053535 0.87 L3MBTL1 (0.43) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL13367581 0.87 ALDH1A1 (0.51) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL12856498 0.86 ALDH1A1 (0.34) TDP1CYP2A6L3MBTL1NPSR1CYP3A4
SCHEMBL21979757 0.86 CYP1A2 (0.46) TDP1CYP2A6L3MBTL1HTTNPSR1
SCHEMBL12856564 0.85 ACHE (0.38) TDP1CYP2A6L3MBTL1CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024301-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2015-05-05 US disclosed
US-9024301-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2015-05-05 US disclosed
US-20130221338-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 US disclosed
US-20130221338-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 US disclosed
US-8450727-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2013-05-28 US disclosed
US-8450727-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2013-05-28 US disclosed
US-20110042660-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2011-02-24 US disclosed
US-20110042660-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2011-02-24 US disclosed
EP-2194110-A1 Electroluminescent device using electroluminescent compounds Gracel Display Inc. (KR) 2010-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110042660-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE AOC1, EBPL, CYBA TDP1 229/4885CYP2A6 2102/4885L3MBTL1 268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.